Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew G Hogan

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The American Surgeon|May 31, 2022
Morbid Obesity Not a Risk for Serious Complications Following Outpatient SurgeryMariana E Tumminello, Matthew G Hogan, Claudia Leonardi, et al.
Cancer Biology & Therapy|January 30, 2013
Stearoyl gemcitabine nanoparticles overcome obesity-induced cancer cell resistance to gemcitabine in a mouse postmenopausal breast cancer modelRebecca E De Angel, Jorge M Blando, Matthew G Hogan, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The American Surgeon|May 31, 2022
Morbid Obesity Not a Risk for Serious Complications Following Outpatient SurgeryMariana E Tumminello, Matthew G Hogan, Claudia Leonardi, et al.
Cancer Biology & Therapy|January 30, 2013
Stearoyl gemcitabine nanoparticles overcome obesity-induced cancer cell resistance to gemcitabine in a mouse postmenopausal breast cancer modelRebecca E De Angel, Jorge M Blando, Matthew G Hogan, et al.
Pageof 1